SCLX
Scilex Holding Company
NASDAQ · Healthcare · Drug Manufacturers - General · US
$5.42
+2.56%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$0.08
- Revenue estimate
- $17.0M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$17
- EPS estimate
- -$0.18
- Revenue actual
- $7.6M
- Revenue estimate
- $16.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -4180.3%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026